CDH5 and neoplasm: Meanwhile, Lupeol downregulates VE-cadherin expression, hindering the maturation of bone marrow-derived endothelial progenitor cells (EPCs) and disrupting the synergistic interaction between angiogenesis and VM in the tumor microenvironment.